The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study.
Therapeutic advances in gastroenterology(2023)
摘要
ChiCTR2200056931.
更多查看译文
关键词
H. pylori,S. boulardii,antofloxacin,quadruple therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要